Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

The presented data show that PHST001, through potent CD24 binding, promotes macrophage-induced phagocytosis in a number of cancer cells and significantly shrinks tumors in vivo. In addition, PHST001 ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

Corvus Pharmaceuticals Inc. (CRVS) announced new data highlighting the potential of ciforadenant, the Company's adenosine A2A ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...

A new study from the USC Norris Comprehensive Cancer Center has found evidence that targeting CD47, a protein that is part of ...

First generation Bria-OTS™ immunotherapy is HLA matched to individual patients and expresses a variety of cancer-related ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

But what a macrophage in the lung adapts to is different from what a macrophage in the uterus or gut adapts to.” “When you design immunotherapy for colorectal cancer, for example, you can't just ...